Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2025 (2)
  • 2024 (2)
  • 2023 (5)
  • 2022 (8)
  • 2021 (9)

Subject

  • Drug Trafficking (138)
  • Synthetic drugs (70)
  • Seizures (Drugs/Property) (47)
  • Major Law Enforcement Operation (41)
  • Arrests/Convictions - Major (38)
  • Task Forces/Task Force Officers (35)
  • Guns/Weapons (33)
  • OCDETF/Task Force (32)
  • Overdose (32)
  • Guilty Plea (20)
  • Fake Pills (16)
  • Gangs (14)
  • Prescription Drugs (13)
  • Narcoterrorism (12)
  • Outreach/Drug Prevention (12)
  • Press Conferences (9)
  • Money Laundering (7)
  • Prevention/Education - DEA websites GSAD, JTT etc (7)
  • HIDTA (5)
  • Public and Media Affairs - also see Congressional Affairs (5)
  • Dark Web- Internet Trafficking (4)
  • Diversion Division (3)
  • International/Foreign Operations (3)
  • Asset Forfeiture (2)
  • Extraditions (1)
  • Intelligence Division - Intelligence Products (1)
  • Intergovernmental Affairs (1)
  • Pharmaceuticals/Pharmacists/Physicians (9)

Drug Name

  • Opioids (19)
  • Oxycodone (16)
  • Synthetic Opioids (8)
  • Morphine (3)
  • Benzodiazepines (2)
  • Hydromorphone (2)
  • Ketamine (2)
  • Steroids (2)
  • Amphetamines (1)
  • Cocaine (1)
  • Heroin (1)
  • Methadone (1)
  • Methamphetamine (1)
  • Fentanyl (9)

Field Division

  • St. Louis (3)
  • Washington, DC (3)
  • Chicago (1)
  • Dallas (1)
  • New York (1)
Clear All Results
PRESS RELEASE

UT Southwestern to Pay $4.5 Million to Resolve Alleged Controlled Substance Act Violations That Permitted Drug Diversion by Staff

Noviembre 30, 2021
Dallas - The University of Texas Southwestern Medical Center has agreed to pay $4.5 million to resolve allegations that its violations of the Controlled Substances Act allowed hospital staff to divert fentanyl and other dangerous drugs from the hospital, announced DEA Dallas Special Agent in Charge, Eduardo A. Chávez. The...
Noviembre 30, 2021
PRESS RELEASE

Man Indicted for Taking Controlled Substances from Kansas Hospital

Noviembre 01, 2021
KANSAS CITY, Kan. – A federal grand jury in Kansas returned an indictment charging an Overland Park, Kansas, man on two counts of tampering with a consumer product, one count of possession of fentanyl by deception and subterfuge, and one count of possession of hydromorphone by deception and subterfuge. According...
Noviembre 01, 2021
PRESS RELEASE

Missouri Woman Indicted for Tampering with Hospitals’ Fentanyl

Octubre 04, 2021
KANSAS CITY, Kan. – A federal grand jury in Kansas City, Kansas, returned an indictment charging a nurse from Kansas City, Missouri, with two counts of tampering with a consumer product and two counts of possession of fentanyl by deception and subterfuge. According to court documents, between January 2020 and...
Octubre 04, 2021
PRESS RELEASE

Physician Assistant Sentenced for Conspiring to Distribute and Dispense Oxycodone, Fentanyl, Methadone, and Alprazolam

Agosto 26, 2021
Baltimore, Md., – U.S. District Judge Richard D. Bennett sentenced William Soyke, age 68, of Hanover, Pennsylvania to 37 months in federal prison, followed by three years of supervised release, for conspiracy to distribute and dispense oxycodone, fentanyl, methadone, and alprazolam outside the scope of professional practice and not for...
Agosto 26, 2021
PRESS RELEASE

Albany Doctor Admits to Violating the Controlled Substance Act

Agosto 09, 2021
ALBANY, NY – Dr. Larry Bruni has agreed to pay the United States $50,000 to resolve allegations that on numerous occasions from 2016 through 2020, he prescribed controlled substances without a legitimate medical purpose or outside the usual course of a professional medical practice, in violation of the Controlled Substances...
Agosto 09, 2021
PRESS RELEASE

Two Chicago Area Physicians Indicted on Narcotics and Health Care Fraud

Julio 27, 2021
CHICAGO — Special Agent in Charge Robert J. Bell, Drug Enforcement Administration-Chicago Division and John R. Lausch, Jr., United States Attorney for the Northern District of Illinois announced that two suburban Chicago physicians have been indicted on federal criminal charges for allegedly prescribing opioids to individuals who lacked a legitimate...
Julio 27, 2021
PRESS RELEASE

DEA Washington Division Issues Warning: “One Pill Can Kill”

Junio 29, 2021
Washington, D.C. – Jarod Forget, Special Agent in Charge (SAC) of the DEA Washington Division, is alerting all area residents to an increase in drug overdose deaths tied to counterfeit pills containing the powerful synthetic opioid, fentanyl. Manufactured by Mexican drug trafficking organizations, and marketed as a medication such as...
Junio 29, 2021
PRESS RELEASE

Three Indicted on Federal Drug Distribution Charges

Junio 10, 2021
CHARLOTTESVILLE, Va. – A husband and wife from Fairfax and their cousin from Spotsylvania were indicted last month for conspiring to distribute controlled substances in Virginia. According to court documents, Fahid Rashid, 30, Akhter Ahmed, 28, and Khalisah Khan, 29, conspired to traffic counterfeit pills containing fentanyl. The defendants, and...
Junio 10, 2021
PRESS RELEASE

Justice Department files lawsuit against Creve Coeur pharmacist for Controlled Substances Act violations

Febrero 24, 2021
ST. LOUIS – In a complaint filed February 23, 2021, by the U.S. Attorney’s Office for the Eastern District of Missouri, the government alleges Elizabeth Dembo unlawfully dispensed controlled substances to patients during her time as the pharmacist-in-charge of Olive Street Pharmacy, LLC. The retail pharmacy is located in the...
Febrero 24, 2021
Showing 1 - 9 of 9 results
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster